IPHANMSHealthcare·Biotechnology#347 in industry

Innate Pharma S.A.

Reports in 16d· 2026-05-13

-21.3% · 90d

$1.40

+0.02 (+1.45%)

News

No News Yet

Press releases and SEC filings for IPHA will appear here as they are published.

Check back later for updates

Key Data

Market Cap$131.4M

Open$1.39

Prev Close$1.38

Day Range$1.36 – $1.40

52W Range$1.17 – $2.63

Volume9,926

P/E (TTM)—

EPS$-0.64

Dividend Yield—

Beta0.74

Revenue Growth-46.70%

Price Target$6.00(+328.6%)

Next Earnings2026-05-13(16d)

Analyst Ratings

Strong Buy4 analysts

Buy 3Hold 1Sell 0

About

Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH45, an antibody drug conjugates (ADC); and IPH67, an undisclosed, multi-specific ANKET. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is based in Marseille, France.

Healthcare · Biotechnology

163 employees

www.innate-pharma.com